AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
Source: Cnbc.com
Original source: https://www.cnbc.com/2026/03/27/astrazeneca-stock-az-trial-lung-drug-shares-tozorakimab.html